Literature DB >> 8911442

Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin.

S L Kläger1, J A Whitworth, M D Downham.   

Abstract

Onchocerca volvulus nodules were removed from 77 fully compliant patients in a longitudinal study of ivermectin treatment in Sierra Leone. The patients had participated in a randomized controlled trial and received either 4 annual doses of ivermectin or 10 6-monthly doses over 6 years. Worms were examined 9 months after the last treatment for evidence of changes in morphology, viability and reproductivity. The findings were compared with results for the 2 groups obtained at earlier surveys of the same study population. Repeated treatment at 6 and 12-month intervals has resulted in a marked ageing of the male worm population profile and a significant reduction in the proportion of live female worms found in the nodules. In addition, there has been a reduction in reproductivity of 90% or more. However, most of the worms found were still alive and potentially fertile, underlining the need for the continuation of regular ivermectin treatment to maintain the benefits achieved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911442     DOI: 10.1111/j.1365-3156.1996.tb00083.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  16 in total

1.  Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.

Authors:  Joseph D Turner; Nicholas Tendongfor; Mathias Esum; Kelly L Johnston; R Stuart Langley; Louise Ford; Brian Faragher; Sabine Specht; Sabine Mand; Achim Hoerauf; Peter Enyong; Samuel Wanji; Mark J Taylor
Journal:  PLoS Negl Trop Dis       Date:  2010-04-13

2.  Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.

Authors:  Mike Y Osei-Atweneboana; Daniel A Boakye; Kwablah Awadzi; John O Gyapong; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-02-12       Impact factor: 4.077

3.  Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.

Authors:  Mike Y Osei-Atweneboana; Kwablah Awadzi; Simon K Attah; Daniel A Boakye; John O Gyapong; Roger K Prichard
Journal:  PLoS Negl Trop Dis       Date:  2011-03-29

4.  Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.

Authors:  Saskia I Johanns; Richard G Gantin; Bawoubadi Wangala; Kossi Komlan; Wemboo A Halatoko; Meba Banla; Potchoziou Karabou; Adrian Jf Luty; Hartwig Schulz-Key; Carsten Köhler; Peter T Soboslay
Journal:  PLoS Negl Trop Dis       Date:  2022-05-03

5.  Repeated high doses of avermectins cause prolonged sterilisation, but do not kill, Onchocerca ochengi adult worms in African cattle.

Authors:  Barend M deC Bronsvoort; Alfons Renz; Virginia Tchakouté; Vincent N Tanya; David Ekale; Alexander J Trees
Journal:  Filaria J       Date:  2005-08-08

6.  Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.

Authors:  Hugues C Nana-Djeunga; Catherine Bourguinat; Sébastien D Pion; Jean Bopda; Jonas A Kengne-Ouafo; Flobert Njiokou; Roger K Prichard; Samuel Wanji; Joseph Kamgno; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

7.  Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.

Authors:  Luc E Coffeng; Wilma A Stolk; Achim Hoerauf; Dik Habbema; Roel Bakker; Adrian D Hopkins; Sake J de Vlas
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

8.  Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.

Authors:  Achim Hoerauf; Sabine Specht; Marcelle Büttner; Kenneth Pfarr; Sabine Mand; Rolf Fimmers; Yeboah Marfo-Debrekyei; Peter Konadu; Alexander Yaw Debrah; Claudio Bandi; Norbert Brattig; Anna Albers; John Larbi; Linda Batsa; Mark J Taylor; Ohene Adjei; Dietrich W Büttner
Journal:  Med Microbiol Immunol       Date:  2007-11-13       Impact factor: 3.402

9.  Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Authors:  Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

10.  Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.

Authors:  Méba Banla; Solim Tchalim; Potochoziou K Karabou; Richard G Gantin; Aide I Agba; Abiba Kére-Banla; Gertrud Helling-Giese; Christoph Heuschkel; Hartwig Schulz-Key; Peter T Soboslay
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.